Center for Brain and Cognition, Computational Neuroscience Group, Department of Information and Communication Technologies, Universitat Pompeu Fabra, Barcelona 08018, Spain.
Yale University, Psychiatry Department, New Haven, 06510, CT, United States.
Neuroimage Clin. 2017 Aug 8;16:343-354. doi: 10.1016/j.nicl.2017.08.006. eCollection 2017.
Alzheimer's disease (AD) is the most common dementia with dramatic consequences. The research in structural and functional neuroimaging showed altered brain connectivity in AD. In this study, we investigated the whole-brain resting state functional connectivity (FC) of the subjects with preclinical Alzheimer's disease (PAD), mild cognitive impairment due to AD (MCI) and mild dementia due to Alzheimer's disease (AD), the impact of APOE4 carriership, as well as in relation to variations in core AD CSF biomarkers. The synchronization in the whole-brain was monotonously decreasing during the course of the disease progression. Furthermore, in AD patients we found widespread significant decreases in functional connectivity (FC) strengths particularly in the brain regions with high global connectivity. We employed a whole-brain computational modeling approach to study the mechanisms underlying these alterations. To characterize the causal interactions between brain regions, we estimated the effective connectivity (EC) in the model. We found that the significant EC differences in AD were primarily located in left temporal lobe. Then, we systematically manipulated the underlying dynamics of the model to investigate simulated changes in FC based on the healthy control subjects. Furthermore, we found distinct patterns involving CSF biomarkers of amyloid-beta (Aβ1 - 42) total tau (t-tau) and phosphorylated tau (p-tau). CSF Aβ1 - 42 was associated to the contrast between healthy control subjects and clinical groups. Nevertheless, tau CSF biomarkers were associated to the variability in whole-brain synchronization and sensory integration regions. These associations were robust across clinical groups, unlike the associations that were found for CSF Aβ1 - 42. APOE4 carriership showed no significant correlations with the connectivity measures.
阿尔茨海默病(AD)是最常见的痴呆症,具有显著的后果。结构和功能神经影像学的研究表明 AD 存在大脑连接改变。在这项研究中,我们研究了临床前阿尔茨海默病(PAD)、AD 引起的轻度认知障碍(MCI)和 AD 引起的轻度痴呆患者的全脑静息状态功能连接(FC),以及 APOE4 携带者的影响,以及与核心 AD CSF 生物标志物变化的关系。在疾病进展过程中,全脑同步性呈单调下降。此外,在 AD 患者中,我们发现功能连接(FC)强度广泛显著降低,特别是在具有高全局连接性的大脑区域。我们采用全脑计算建模方法来研究这些改变的潜在机制。为了描述大脑区域之间的因果相互作用,我们在模型中估计了有效连接(EC)。我们发现 AD 中显著的 EC 差异主要位于左侧颞叶。然后,我们系统地操纵模型的潜在动力学,根据健康对照组研究基于 FC 的模拟变化。此外,我们发现了涉及淀粉样蛋白-β(Aβ1-42)总tau(t-tau)和磷酸化 tau(p-tau)的脑脊液生物标志物的不同模式。CSF Aβ1-42 与健康对照组和临床组之间的对比有关。然而,tau CSF 生物标志物与全脑同步性和感觉整合区域的变异性有关。这些关联在整个临床组中是稳健的,与 CSF Aβ1-42 的关联不同。APOE4 携带者与连接测量值没有显著相关性。